Legal Representation
Attorney
Corey K. Cho
USPTO Deadlines
Next Deadline
1509 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-08-25)
Due Date
August 25, 2029
Grace Period Ends
February 25, 2030
Application History
44 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 23, 2019 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Mar 23, 2019 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Mar 23, 2019 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Mar 20, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Mar 7, 2019 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Aug 25, 2018 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Dec 23, 2014 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Dec 22, 2014 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Dec 22, 2014 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Dec 3, 2014 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Jul 28, 2014 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 25, 2009 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 9, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 20, 2009 | NPUB | O | NOTICE OF PUBLICATION |
| May 5, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Apr 29, 2009 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 29, 2009 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Apr 29, 2009 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Apr 29, 2009 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Apr 29, 2009 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Apr 28, 2009 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Apr 13, 2009 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Apr 1, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Mar 26, 2009 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 12, 2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 11, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 11, 2009 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 18, 2009 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 18, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 18, 2009 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Jan 26, 2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 26, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 22, 2009 | ALIE | A | ASSIGNED TO LIE |
| Jan 22, 2009 | ALIE | A | ASSIGNED TO LIE |
| Dec 17, 2008 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Dec 17, 2008 | ALIE | A | ASSIGNED TO LIE |
| Dec 8, 2008 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Dec 8, 2008 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 4, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 16, 2008 | CNRT | F | NON-FINAL ACTION MAILED |
| Jun 14, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 4, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 4, 2008 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Feb 28, 2008 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 016
Publications, namely, printed instructional and teaching materials, brochures, pamphlets, bulletins, newsletters and magazines, all in the field of health care, cancer protection, prevention, detection and treatment, medical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases
First Use Anywhere:
Nov 30, 2007
First Use in Commerce:
Nov 30, 2007
Class 041
Medical educational services, namely, conducting lectures, seminars and workshops to health care practitioners, patients and patient caregivers in the field of health care, cancer care and prevention of cancer, and medical diagnostics, prognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases
First Use Anywhere:
Nov 30, 2007
First Use in Commerce:
Nov 30, 2007
Class 042
Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicians, patients and researchers, namely, an online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseases, namely, providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, providing objective data in usable form on the effectiveness of a drug or diagnostic test
First Use Anywhere:
Dec 31, 2007
First Use in Commerce:
Dec 31, 2007
Class 044
Providing health care, medical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; medical services, namely, cancer care and prevention of cancer, and medical diagnostics, prognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counseling, namely, offering advice regarding cancer prevention, detection, treatment and clinical testing in the field of cancer and other diseases
First Use Anywhere:
Nov 30, 2007
First Use in Commerce:
Nov 30, 2007
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
016
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CANCER CENTER"